Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ibrahim Uygun

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Pediatric Surgery International|February 10, 2016
Predicting pseudocyst formation following pancreatic trauma in pediatric patientsBahattin Aydogdu, Serkan Arslan, Hikmet Zeytun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
Phase I Trial Combining Chemokine-Targeting with Loco-Regional Chemoimmunotherapy for Recurrent, Platinum-Sensitive Ovarian Cancer Shows Induction of CXCR3 Ligands and Markers of Type 1 ImmunityBrian Orr, Haider Mahdi, Yusi Fang, et al.
Disease Models & Mechanisms|July 11, 2025
Murine cell lines with defined mutations model different histological subtypes of epithelial ovarian cancerLixin Zhang, Yusi Fang, Ibrahim Uygun, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Pediatric Surgery International|February 10, 2016
Predicting pseudocyst formation following pancreatic trauma in pediatric patientsBahattin Aydogdu, Serkan Arslan, Hikmet Zeytun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
Phase I Trial Combining Chemokine-Targeting with Loco-Regional Chemoimmunotherapy for Recurrent, Platinum-Sensitive Ovarian Cancer Shows Induction of CXCR3 Ligands and Markers of Type 1 ImmunityBrian Orr, Haider Mahdi, Yusi Fang, et al.
Disease Models & Mechanisms|July 11, 2025
Murine cell lines with defined mutations model different histological subtypes of epithelial ovarian cancerLixin Zhang, Yusi Fang, Ibrahim Uygun, et al.
Pageof 4